Table 1 Clinical characteristics of the colon cancer patients in three cohorts.

From: Predicting immunotherapy prognosis and targeted therapy sensitivity of colon cancer based on a CAF-related molecular signature

 

TCGA-COAD (n = 446)

GSE39582 (n = 562)

ZHSU (n = 157)

Status (%)

 Alive

350 (78.5)

371 (66.0)

144 (91.7)

 Dead

96 (21.5)

191 (34.0)

13 (8.3)

Age (median, range)

67.0 (31–90)

66.9 (22–97)

67.1 (25–95)

Gender (%)

 Female

212 (47.5)

253 (45.0)

52 (33.1)

 Male

234 (52.5)

309 (55.0)

105 (66.9)

TNM stage (%)

 I

75 (16.8)

32 (5.7)

4 (2.6)

 II

175 (39.2)

262 (46.6)

43 (27.4)

 III

124 (27.8)

204 (36.3)

85 (54.1)

 IV

61 (13.7)

60 (10.7)

25 (15.9)

Unknown

11 (2.5)

4 (0.7)

0 (0)

Back to article page